NMDA receptor dysregulation in chronic state: A possible mechanism underlying depression with BDNF downregulation

Neurochemistry International

Volumn 79, Issue , 2014, Pages 88-97

  Vásquez, Carol E ^a,b   Riener, Romina ^c   Reynolds, Elaine ^d   Britton, Gabrielle B ^a  

^a INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^b ACHARYA NAGARJUNA UNIVERSITY   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAFAYETTE COLLEGE   (United States)

Author keywords

Calcium signaling; Glutamate; Hippocampus; Psychological; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

CALCIUM SIGNALING; CHRONIC STRESS; DEPRESSION; DOWN REGULATION; EPIGENETICS; GENETIC REGULATION; HUMAN; NEUROTRANSMISSION; REVIEW; RISK FACTOR; ANIMAL; BIOSYNTHESIS; GENETIC EPIGENESIS; GENETICS; MENTAL STRESS; METABOLISM; PSYCHOLOGY;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DOWN-REGULATION; EPIGENESIS, GENETIC; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS, PSYCHOLOGICAL;

EID: 84911461346     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.09.007     Document Type: Review

References (135)

1. Adasme, T., Haeger, P., Paula-Lima, A.C., Espinoza, I., Casas-Alarcón, M.M., Carrasco, M.A., et al., 2011. Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. PNAS 108 (7), 3029-3034.
2. Aguilar-Valles, A., Sánchez, E., de Gortari, P., Balderas, I., Ramírez-Amaya, V., Bermúdez-Rattoni, F., et al., 2005. Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions. Neuroendocrinology 82 (5-6), 306-319.
3. Akinfiresoye, L., Tizabi, Y., 2013. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Psychopharmacology (Berl) 230 (2), 291-298.
4. Allaman, I., Papp, M., Kraftsik, R., Fiumelli, H., Magistretti, P.J., Martin, J.-L., 2008. Expression of brain-derived neurotrophic factor is not modulated by chronicmild stress in the rat hippocampus and amygdala. Pharmacol. Rep. 60 (6), 1001-1007.
5. Andrade, A.L., Rossi, D.J., 2010. Simulated ischaemia induces Ca2+-independent glutamatergic vesicle release through actin filament depolymerization in area CA1 of the hippocampus. J. Physiol. 588 (9), 1499-1514.
6. Aoki, C., Wu, K., Elste, A., Len, G., Lin, S., McAuliffe, G., et al., 2000. Localization of brain-derived neurotrophic factor and trkb receptors to postsynaptic densities of adult rat cerebral cortex. J. Neurosci. Res. 59 (3), 454-463.
7. Autry, A.E., Adachi, M., Nosyreva, E., Na, E.S., Los, M.F., Cheng, P., et al., 2011. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475 (7354), 91-95.
8. Balkowiec, A., Katz, D.M., 2002. Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J. Neurosci. 22 (23), 10399-10407.
9. Bath, K.G., Jing, D.Q., Dincheva, I., Neeb, C.C., Pattwell, S.S., Chao, M., V, et al., 2012. BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity. Neuropsychopharmacology 37 (5), 1297-1304.
10. Berezova, I., V, Shishkina, G.T., Kalinina, T.S., Dygalo, N.N., 2012. Behavior in a forced swimming test and expression of the genes for a neurotrophic factor (BDNF) and antiapoptotic protein Bcl-xl. Neurosci. Behav. Physiol. 42 (9), 1040-1045.
11. Bergström, A., Jayatissa, M.N., Mørk, A., Wiborg, O., 2008. Stress sensitivity and resilience in the chronic mild stress rat model of depression: an in situ hybridization study. Brain Res. 1196, 41-52.
12. Bradshaw, J.M., Kubota, Y., Meyer, T., Schulman, H., 2003. An ultrasensitive Ca2+/calmodulin-dependent protein kinase II-protein phosphatase 1 switch facilitates specificity in postsynaptic calcium signaling. PNAS 100 (18), 10512-10517.
13. Brunetti, M., Sepede, G., Mingoia, G., Catani, C., Ferretti, A., Merla, A., et al., 2010. Elevated response of human amygdala to neutral stimuli in mild post traumatic stress disorder: neural correlates of generalized emotional response. Neuroscience 168 (3), 670-679.
14. Bueller, J.A., Aftab, M., Sen, S., Gomez-Hassan, D., Burmeister, M., Zubieta, J.-K., 2006. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 59 (9), 812-815.
15. Burgdorf, J., Zhang, X., Nicholson, K.L., Balster, R.L., David Leander, J., Stanton, P.K., et al., 2013. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 38 (5), 729-742.
16. Calabrese, F., Molteni, R., Racagni, G., Riva, M.A., 2009. Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34 (Suppl. 1), S208-S216.
17. Calabrese, F., Guidotti, G., Molteni, R., Racagni, G., Mancini, M., Riva, M.A., 2012. Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment. PLoS ONE 7 (5), e37916.
18. Caldeira, M.V., Melo, C.V., Pereira, D.B., Carvalho, R.F., Carvalho, A.L., Duarte, C.B., 2007. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol. Cell. Neurosci. 35 (2), 208-219.
19. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., et al., 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 (5646), 885-889.
20. Chen, Z.-Y., Patel, P.D., Sant, G., Meng, C.-X., Teng, K.K., Hempstead, B.L., et al., 2004. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24 (18), 4401-4411.
21. Chen, Z.-Y., Ieraci, A., Teng, H., Dall, H., Meng, C.-X., Herrera, D.G., et al., 2005. Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J. Neurosci. 25 (26), 6156-6166.
22. Chen, Z.-Y., Jing, D., Bath, K.G., Ieraci, A., Khan, T., Siao, C.-J., et al., 2006. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314 (5796), 140-143.
23. Christian, K.M., Miracle, A.D., Wellman, C.L., Nakazawa, K., 2011. Chronic stress-induced hippocampal dendritic retraction requires CA3 NMDA receptors. Neuroscience 174, 26-36.
24. Cies̈lik, K., Sowa-Kućma, M., Ossowska, G., Legutko, B., Wolak, M., Opoka, W., et al., 2011. Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol. Rep. 63 (2), 537-543.
25. Colzato, L.S., Van der Does, A.J.W., Kouwenhoven, C., Elzinga, B.M., Hommel, B., 2011. BDNF Val66Met polymorphism is associated with higher anticipatory cortisol stress response, anxiety, and alcohol consumption in healthy adults. Psychoneuroendocrinology 36 (10), 1562-1569.
26. Costa-Nunes, J., Zubareva, O., Araújo-Correia, M., Valenc¸a, A., Schroeter, C.A., Pawluski, J.L., et al., 2013. Altered emotionality, hippocampus-dependent performance and expression of NMDA receptor subunit mRNAs in chronically stressedmice. Stress 17 (1), 108-116.
27. Crozier, R., Caixia, B., Han, Y., Plummer, M., 2008. BDNF modulation of NMDA receptors is activity dependent. J. Neurophysiol. 100 (6), 3264-3274.
28. Deisseroth, K., Heist, E.K., Tsien, R.W., 1998. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392 (6672), 198-202.
29. DiazGranados, N., Ibrahim, L.A., Brutsche, N.E., Ameli, R., Henter, I.D., Luckenbaugh, D.A., et al., 2010. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder. J. Clin. Psychiatry 71 (12), 1605-1611.
30. Du, J., Feng, L., Yang, F., Lu, B., 2000. Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J. Cell Biol. 150 (6), 1423-1434.
31. Du, J., Feng, L., Zaitsev, E., Je, H.-S., Liu, X., Lu, B., 2003. Regulation of TrkB receptor tyrosine kinase and its internalization by neuronal activity and Ca2+ influx. J. Cell Biol. 163 (2), 385-395.
32. Duman, R.S., Li, N., Liu, R.-J., Duric, V., Aghajanian, G., 2012. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62 (1), 35-41.
33. Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., et al., 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2), 257-269.
34. Eisch, A.J., Bolaños, C.A., de Wit, J., Simonak, R.D., Pudiak, C.M., Barrot, M., et al., 2003. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol. Psychiatry 54 (10), 994-1005.
35. Elmariah, S.B., Crumling, M.A., Parsons, T.D., Balice-Gordon, R.J., 2004. Postsynaptic TrkB-mediated signaling modulates excitatory and inhibitory neurotransmitter receptor clustering at hippocampal synapses. J. Neurosci. 24 (10), 2380-2393.
36. Fang, Z.H., Lee, C.H., Seo, M.K., Cho, H., Lee, J.G., Lee, B.J., et al., 2013. Effect of treadmill exercise on the BDNF-mediated pathway in the hippocampus of stressed rats. Neurosci. Res. 76 (4), 187-194.
37. Ferguson, J.M., Shingleton, R.N., 2007. An open-label, flexible-dose study of memantine in major depressive disorder. Clin. Neuropharmacol. 30 (3), 136-144.
38. Fontella, F.U., Vendite, D.A., Tabajara, A.S., Porciúncula, L.O., da Silva Torres, I.L., Jardim, F.M., et al., 2004. Repeated restraint stress alters hippocampal glutamate uptake and release in the rat. Neurochem. Res. 29 (9), 1703-1709.
39. Garcia, L.S.B., Comim, C.M., Valvassori, S.S., Réus, G.Z., Barbosa, L.M., Andreazza, A.C., et al., 2008. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog. Neuropsychopharmacol Biol. Psychiatry 32 (1), 140-144.
40. Gerges, N.Z., Aleisa, A.M., Schwarz, L.A., Alkadhi, K.A., 2003. Chronic psychosocial stress decreases calcineurin in the dentate gyrus: a possible mechanism for preservation of early LTP. Neuroscience 117 (4), 869-874.
41. Gerges, N.Z., Aleisa, A.M., Schwarz, L.A., Alkadhi, K.A., 2004. Reduced basal CaMKII levels in hippocampal CA1 region: possible cause of stress-induced impairment of LTP in chronically stressed rats. Hippocampus 14 (3), 402-410.
42. Ghosh, A., Carnahan, J., Greenberg, M.E., 1994. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263 (5153), 1618-1623.
43. Gideons, E.S., Kavalali, E.T., Monteggia, L.M., 2014. Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc. Natl. Acad. Sci. U.S.A. 111 (23), 8649-8654.
44. Groves, J.O., 2007. Is it time to reassess the BDNF hypothesis of depression? Mol. Psychiatry 12 (12), 1079-1088.
45. Grønli, J., Bramham, C., Murison, R., Kanhema, T., Fiske, E., Bjorvatn, B., et al., 2006. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol. Biochem. Behav. 85 (4), 842-849.
46. Heise, C., Gardoni, F., Culotta, L., di Luca, M., Verpelli, C., Sala, C., 2014. Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons. Front. Cell. Neurosci. 8, 35.
47. Huang, C.C., Wei, I.H., Huang, C.L., Chen, K.T., Tsai, M.H., Tsai, P., et al., 2013. Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biol. Psychiatry 74 (10), 734-741.
48. Ibrahim, L., Diazgranados, N., Luckenbaugh, D.A., Machado-Vieira, R., Baumann, J., Mallinger, A.G., et al., 2011. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog. Neuropsychopharmacol Biol. Psychiatry 35 (4), 1155-1159.
49. Jiang, X., Tian, F., Mearow, K., Okagaki, P., Lipsky, R.H., Marini, A.M., 2005. The excitoprotective effect of N-methyl-D-aspartate receptors is mediated by a brain-derived neurotrophic factor autocrine loop in cultured hippocampal neurons. J. Neurochem. 94 (3), 713-722.
50. Kang, H., Jia, L.Z., Suh, K.Y., Tang, L., Schuman, E.M., 1996. Determinants of BDNF-induced hippocampal synaptic plasticity: role of the Trk B receptor and the kinetics of neurotrophin delivery. Learn. Mem. 3 (2-3), 188-196.
51. Khan, A., Faucett, J., Lichtenberg, P., Kirsch, I., Brown, W.A., 2012. A systematic review of comparative efficacy of treatments and controls for depression. PLoS ONE 7 (7), e41778.
52. Kingsbury, T.J., Murray, P.D., Bambrick, L.L., Krueger, B.K., 2003. Ca(2+)-dependent regulation of TrkB expression in neurons. J. Biol. Chem. 278 (42), 40744-40748.
53. Kolarow, R., Brigadski, T., Lessmann, V., 2007. Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J. Neurosci. 27 (39), 10350-10364.
54. Koob, G.F., 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (5), 177-184.
55. Kotermanski, S.E., Wood, J.T., Johnson, J.W., 2009. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping. J. Physiol. 587 (Pt 19), 4589-4604.
56. Lakshminarasimhan, H., Chattarji, S., 2012. Stress leads to contrasting effects on the levels of brain derived neurotrophic factor in the hippocampus and amygdala. PLoS ONE 7 (1), e30481.
57. Lanthorn, T.H., Mealing, G.A.R., Morley, P., 2000. Differences in degree of trapping between AR-R15896 and other uncompetitive NMDA receptor antagonists. Amino Acids 19 (1), 173-175.
58. Larsen, M.H., Mikkelsen, J.D., Hay-Schmidt, A., Sandi, C., 2010. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J. Psychiatr. Res. 44 (13), 808-816.
59. Lee, J., Duan, W., Mattson, M.P., 2002. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 82 (6), 1367-1375.
60. Li, J., Zhou, Y., Liu, B.B., Liu, Q., Geng, D., Weng, L.J., et al., 2013. Nobiletin ameliorates the deficits in hippocampal BDNF, TrkB, and synapsin I induced by chronic unpredictable mild stress. Evid. Based Complement. Alternat. Med. 2013, Article ID 359682.
61. Li, J.-J., Yuan, Y.-G., Hou, G., Zhang, X.-R., 2011a. Dose-related effects of venlafaxine on pCREB and brain-derived neurotrophic factor (BDNF) in the hippocampus of the rat by chronic unpredictable stress. Acta Neuropsychiatrica 23 (1), 20-30.
62. Li, L., Stefan, M.I., Le Nove, N., 2012. Calcium input frequency, duration and amplitude differentially modulate the relative activation of calcineurin and CaMKII. PLoS ONE 7 (9), e43810.
63. Li, N., Liu, R., Dwyer, J., Banasr, M., Lee, B., Son, H., et al., 2011. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry 69 (8), 754-761.
64. Li, N., He, X., Zhang, Y., Qi, X., Li, H., Zhu, X., et al., 2011b. Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine. Int. J. Neuropsychopharmacol. 14 (8), 1091-1098.
65. Li, X.-H., Liu, N.-B., Zhang, M.-H., Zhou, Y.-L., Liao, J.-W., Liu, X.-Q., et al., 2007. Effects of chronic multiple stress on learning and memory and the expression of Fyn, BDNF, TrkB in the hippocampus of rats. Chin. Med. J. 120 (8), 669-674.
66. Lindholm, D., Carroll, P., Tzimagiogis, G., Thoenen, H., 1996. Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4. Eur. J. Neurosci. 8 (7), 1452-1460.
67. Liu, X., Chan, C.-B., Jang, S.-W., Pradoldej, S., Huang, J., He, K., et al., 2010. A synthetic 7,8-dihydroxyflavone derivative promotes neurogenesis and exhibits potent antidepressant effect. J. Med. Chem. 53 (23), 8274-8286.
68. Liu, X., Betzenhauser, M.J., Reiken, S., Meli, A.C., Xie, W., Chen, B.-X., et al., 2012. Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. Cell 150 (5), 1055-1067.
69. Long, K.D., Mastropaolo, J., Rosse, R.B., Manaye, K.F., Deutsch, S.I., 2006. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain. Brain Res. Bull. 69 (6), 626-630.
70. Lu, Y., Hawkins, R., 2002. Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus. J. Neurophysiol. 88 (3), 1270-1278.
71. Madara Eric, J.C.L., 2008. Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission. J. Neurophysiol. 100 (6), 3175-3184.
72. Mao, Q., Huang, Z., Zhong, X., 2014. Piperine reverses chronic unpredictable mild stress-induced behavioral and biochemical alterations in rats. Cell. Mol. Neurobiol. 34 (3), 403-408.
73. Marmigère, F., Givalois, L., Rage, F., Arancibia, S., Tapia-Arancibia, L., 2003. Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 13 (5), 646-655.
74. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., et al., 2003. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302 (5646), 890-893.
75. McCarty, J.H., Feinstein, S.C., 1998. Activation loop tyrosines contribute varying roles to TrkB autophosphorylation and signal transduction. Oncogene 16 (13), 1691-1700.
76. Miller, S.G., Kennedy, M.B., 1986. Regulation of brain type II Ca2 + /calmodulindependent protein kinase by autophosphorylation: a Ca2+-triggered molecular switch. Cell 44 (6), 861-870.
77. Moskal, J.R., Kuo, A.G., Weiss, C., Wood, P.L., O'Connor Hanson, A., Kelso, S., et al., 2005. GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl- D-aspartate receptor modulator. Neuropharmacology 49 (7), 1077-1087.
78. Murakami, S., Imbe, H., Morikawa, Y., Kubo, C., Senba, E., 2005. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci. Res. 53 (2), 129-139.
79. Murrough, J.W., Iosifescu, D.V., Chang, L.C., Al Jurdi, R.K., Green, C.E., Perez, A.M., et al., 2013. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am. J. Psychiatry 170 (10), 1134-1142.
80. Musazzi, L., Cattaneo, A., Tardito, D., Barbon, A., Gennarelli, M., Barlati, S., et al., 2009. Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants. BMC Neurosci. 10, 48.
81. Nair, A., Bonneau, R.H., 2006. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J. Neuroimmunol. 171 (1), 72-85.
82. Nair, A., Vadodaria, K.C., Banerjee, S.B., Benekareddy, M., Dias, B.G., Duman, R.S., et al., 2007. Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus. Neuropsychopharmacology 32 (7), 1504-1519.
83. Norris, E., Thibault, O., Brewer, L., Clodfelter, G., Porter, N., Landfield, P., et al., 2006. Electrophysiological mechanisms of delayed excitotoxicity: positive feedback loop between NMDA receptor current and depolarization-mediated glutamate release. J. Neurophysiol. 96 (5), 2488-2500.
84. Nosyreva, E., Szabla, K., Autry, A.E., Ryazanov, A.G., Monteggia, L.M., Kavalali, E.T., 2013. Acute suppression of spontaneous neurotransmission drives synaptic potentiation. J. Neurosci. 33 (16), 6990-7002.
85. Pardon, M.C., Roberts, R.E., Marsden, C.A., Bianchi, M., Latif, M.L., Duxon, M.S., et al., 2005. Social threat and novel cage stress-induced sustained extracellular-regulated kinase1/2 (ERK1/2) phosphorylation but differential modulation of brain-derived neurotrophic factor (BDNF) expression in the hippocampus of NMRI mice. Neuroscience 132 (3), 561-574.
86. Park, S.W., Lee, S.K., Kim, J.M., Yoon, J.S., Kim, Y.H., 2006. Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats. Neurosci. Lett. 402 (1-2), 25-29.
87. Pattwell, S.S., Bath, K.G., Perez-Castro, R., Lee, F.S., Chao, M., V, Ninan, I., 2012. The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex. J. Neurosci. 32 (7), 2410-2421.
88. Pilar-Cuéllar, F., Vidal, R., Pazos, A., 2012. Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects. Br. J. Pharmacol. 165 (4b), 1046-1057.
89. Pittenger, C., Duman, R.S., 2007. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33 (1), 88-109.
90. Radecki, D.T., Brown, L.M., Martinez, J., Teyler, T.J., 2005. BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 15 (2), 246-253.
91. Roth, T.L., Zoladz, P.R., Sweatt, J.D., Diamond, D.M., 2011. Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder. J. Psychiatr. Res. 45 (7), 919-926.
92. Ruiz, A., Matute, C., Alberdi, E., 2009. Endoplasmic reticulum Ca(2+) release through ryanodine and IP(3) receptors contributes to neuronal excitotoxicity. Cell Calcium 46 (4), 273-281.
93. Rumi-Masante, J., Rusinga, F.I., Lester, T.E., Dunlap, T.B., Williams, T.D., Dunker, A.K., et al., 2012. Structural basis for activation of calcineurin by calmodulin. J. Mol. Biol. 415 (12), 307-317.
94. Rybakowski, J.K., Permoda-Osip, A., Skibinska, M., Adamski, R., Bartkowska-Sniatkowska, A., 2013. Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? Hum. Psychopharmacol. 28 (1), 87-90.
95. Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., et al., 2003. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 23 (1), 349-357.
96. Sanacora, G., Smith, M.A., Pathak, S., Su, H.-L., Boeijinga, P.H., McCarthy, D.J., et al., 2014. Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects. Mol. Psychiatry 19 (9), 978-985.
97. Sanhueza, M., Fernandez-Villalobos, G., Stein, I.S., Kasumova, G., Zhang, P., Bayer, K.U., et al., 2011. Role of the CaMKII/NMDA receptor complex in the maintenance of synaptic strength. J. Neurosci. 31 (25), 9170-9178.
98. Sanz-Clemente, A., Gray, J.A., Ogilvie, K.A., Nicoll, R.A., Roche, K.W., 2013. Activated CaMKII couples GluN2B and casein kinase 2 to control synaptic NMDA receptors. Cell Rep. 3 (3), 607-614.
99. Schmidt, H.D., Duman, R.S., 2010. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 35 (12), 2378-2391.
100. Schüle, C., Zill, P., Baghai, T.C., Eser, D., Zwanzger, P., Wenig, N., et al., 2006. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 31 (8), 1019-1025.
101. Shalev, I., Lerer, E., Israel, S., Uzefovsky, F., Gritsenko, I., Mankuta, D., et al., 2009. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 34 (3), 382-388.
102. Shieh, P.B., Ghosh, A., 1999. Molecular mechanisms underlying activity-dependent regulation of BDNF expression. J. Neurobiol. 41 (1), 127-134.
103. Sirianni, R.W., Olausson, P., Chiu, A.S., Taylor, J.R., Saltzman, W.M., 2010. The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats. Brain Res. 1321, 40-50.
104. Soliman, F., Glatt, C.E., Bath, K.G., Levita, L., Jones, R.M., Pattwell, S.S., et al., 2010. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 327 (5967), 863-866.
105. Soriano, F.X., Papadia, S., Hofmann, F., Hardingham, N.R., Bading, H., Hardingham, G.E., 2006. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J. Neurosci. 26 (17), 4509-4518.
106. Souery, D., Papakostas, G.I., Trivedi, M.H., 2006. Treatment-resistant depression. J. Clin. Psychiatry 67 (Suppl. 6), 16-22.
107. Stanton, P.K., Potter, P.E., Aguilar, J., Decandia, M., Moskal, J.R., 2009. Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13. Neuroreport 20 (13), 1193-1197.
108. Taliaz, D., Loya, A., Gersner, R., Haramati, S., Chen, A., Zangen, A., 2011. Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J. Neurosci. 31 (12), 4475-4483.
109. Tao, X., Finkbeiner, S., Arnold, D.B., Shaywitz, A.J., Greenberg, M.E., 1998. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20 (4), 709-726.
110. Tao, X., West, A.E., Chen, W.G., Corfas, G., Greenberg, M.E., 2002. A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF. Neuron 33 (3), 383-395.
111. Thalhammer, A., Rudhard, Y., Tigaret, C.M., Volynski, K.E., Rusakov, D.A., Schoepfer, R., 2006. CaMKII translocation requires local NMDA receptor-mediated Ca2+ signaling. EMBO J. 25 (24), 5873-5883.
112. Tian, F., Marini, A.M., Lipsky, R.H., 2010. NMDA receptor activation induces differential epigenetic modification of Bdnf promoters in hippocampal neurons. Amino Acids 38 (4), 1067-1074.
113. Tordera, R.M., Garcia-García, A.L., Elizalde, N., Segura, V., Aso, E., Venzala, E., et al., 2011. Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex. Eur. Neuropsychopharmacol. 21 (1), 23-32.
114. Trivedi, M.H., Rush, A.J., Wisniewski, S.R., Nierenberg, A.A., Warden, D., Ritz, L., et al., 2006. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR∗D: implications for clinical practice. Am. J. Psychiatry 163 (1), 28-40.
115. Tsankova, N.M., Berton, O., Renthal, W., Kumar, A., Neve, R.L., Nestler, E.J., 2006. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9 (4), 519-525.
116. Whitehead, G., Jo, J., Hogg, E.L., Piers, T., Kim, D.-H., Seaton, G., et al., 2013. Acute stress causes rapid synaptic insertion of Ca2 +-permeable AMPA receptors to facilitate long-term potentiation in the hippocampus. Brain 136 (Pt 12), 3753-3765.
117. Won, S.J., Kim, D.Y., Gwag, B.J., 2002. Cellular and molecular pathways of ischemic neuronal death. J. Biochem. Mol. Biol. 35 (1), 67-86.
118. World Health Organization, 2012. Depression. Fact sheet N° 369. 〈http://www.who.int/mediacentre/factsheets/fs369/en〉.
119. Wu, G.Y., Deisseroth, K., Tsien, R.W., 2001. Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Proc. Natl Acad. Sci. U.S.A. 98 (5), 2808-2813.
120. Xiao, L., Shu, C., Tang, J., Wang, H., Liu, Z., Wang, G., 2011. Effects of different CMS on behaviors, BDNF/CREB/Bcl-2 expression in rat hippocampus. Biomed. Aging Pathol. 1 (3), 138-146.
121. Xie, Y., Huang, X., Hu, S., Zhang, Y., Wang, Y., Qiu, X., et al., 2013. The involvement of AMPA-ERK1/2-BDNF pathway in the mechanism of new antidepressant action of prokinetic meranzin hydrate. Amino Acids 44 (2), 413-422.
122. Xu, H., Luo, C., Richardson, J.S., Li, X.M., 2004. Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine. Pharmacogenomics J. 4 (5), 322-331.
123. Xu, H., Chen, Z., He, J., Haimanot, S., Li, X., Dyck, L., et al., 2006. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16 (6), 551-559.
124. Yang, C., Hu, Y.-M., Zhou, Z.-Q., Zhang, G.-F., Yang, J.-J., 2012. Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Ups. J. Med. Sci. 118 (1), 3-8.
125. Ye, Y., Wang, G., Wang, H., Wang, X., 2011. Brain-derived neurotrophic factor (BDNF) infusion restored astrocytic plasticity in the hippocampus of a rat model of depression. Neurosci. Lett. 503 (1), 15-19.
126. Yoshii, A., Constantine-Paton, M., 2010. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev. Neurobiol. 70 (5), 304-322.
127. Yu, H., Chen, Z., 2011. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol. Sin. 32 (1), 3-11.
128. Yu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F.S., Chen, Z.-Y., 2012. Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J. Neurosci. 32 (12), 4092-4101.
129. Zarate, C.A.J., Singh, J.B., Quiroz, J.A., De Jesus, G., Denicoff, K.K., Luckenbaugh, D.A., et al., 2006. A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am. J. Psychiatry 163 (1), 153-155.
130. Zarate, C.A.J., Mathews, D., Ibrahim, L., Chaves, J.F., Marquardt, C., Ukoh, I., et al., 2013. A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. Biol. Psychiatry 74 (4), 257-264.
131. Zhang, H.X., Hyrc, K., Thio, L.L., 2009. The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine. J. Physiol. 587 (13), 3207-3220.
132. Zhang, R., Peng, Z., Wang, H., Xue, F., Chen, Y., Wang, Y., et al., 2014. Gastrodin ameliorates depressive-like behaviors and up-regulates the expression of BDNF in the hippocampus and hippocampal-derived astrocyte of rats. Neurochem. Res. 39 (1), 172-179.
133. Zhang, X.L., Sullivan, J.A., Moskal, J.R., Stanton, P.K., 2008. A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus. Neuropharmacology 55 (7), 1238-1250.
134. Zhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., Yang, J.-J., 2014. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur. Psychiatry 29 (7), 419-423.
135. Zhou, Z., Hong, E.J., Cohen, S., Zhao, W.-N., Ho, H.-Y.H., Schmidt, L., et al., 2006. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52 (2), 255-269.